Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set
Ciro Manzo,1 Maria Natale2 1Department of Geriatric and Internal Medicine, 2Geriatric Rheumatologic Outpatient Clinic, Hospital “Mariano Lauro,” Sant’Agnello, Naples, Italy Abstract: In the last few years, the relationship between polymyalgia rheumatica (PMR) and cancer...
Guardado en:
Autores principales: | Manzo C, Natale M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/faaae872fea44a4898d132d4a742e043 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment
por: Brawer AE
Publicado: (2016) -
A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
por: Hoon E, et al.
Publicado: (2019) -
Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
por: Ciro Manzo, et al.
Publicado: (2021) -
Polymyalgia rheumatica following infective triggersor vaccinations: a different subset of disease?
por: Paolo Falsetti, et al.
Publicado: (2020) -
Polymyalgia rheumatica with normal inflammatory indices at the time of diagnosis: can we just move a step forward?
por: Ciro Manzo, et al.
Publicado: (2020)